In Tuesday’s Wall Street session, Merck & Co Inc (NYSE:MRK) shares traded at $83.29, up 0.34% from the previous session.
MRK stock price is now -14.06% away from the 50-day moving average and -25.79% away from the 200-day moving average. The market capitalization of the company currently stands at $210.69B.
With the price target reduced from $128 to $105, Deutsche Bank Downgraded its rating from Buy to Hold for Merck & Co Inc (NYSE: MRK). On February 10, 2025, TD Cowen Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $121 to quote $100, while ‘Truist’ rates the stock as ‘Hold’
In other news, DAVID WILLIAMS, Officer bought 6,000 shares of the company’s stock on Feb 13 ’25. The stock was bought for $512,057 at an average price of $85.34. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 13 ’25, EVP,Chief Info&Digital Officer Williams David Michael sold 6,000 shares of the business’s stock. A total of $512,057 was realized by selling the stock at an average price of $85.34. This leaves the insider owning 24,123 shares of the company worth $2.01 million. A total of 0.12% of the company’s stock is owned by insiders.
During the past 12 months, Merck & Co Inc has had a low of $82.09 and a high of $134.63. As of last week, the company has a debt-to-equity ratio of 0.86, a current ratio of 1.36, and a quick ratio of 1.15.
The net profit margin was 26.62% and return on equity was 28.33% for MRK. The company reported revenue of $15.62 billion for the quarter, compared to $14.63 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.79 percent.
